Corporate

  • March 25, 2026

    Cognizant Must Face Clorox's $380M Suit Over Login Sharing

    A California state judge has trimmed Clorox's $380 million lawsuit accusing the cybersecurity company Cognizant of enabling a "catastrophic" 2023 cyberattack by voluntarily handing over Clorox employee passwords after hackers merely asked for them, tossing an intentional misrepresentation claim but keeping the bulk of the suit alive.

  • March 25, 2026

    Payments Co. Sued Over $3M Liquidity Pool Loan Default

    Payken is facing a Delaware Chancery Court lawsuit alleging the blockchain-based payments company owes roughly $3.2 million after breaching a master credit agreement and failing to repay loans owed to a jointly owned lending vehicle created to provide it with liquid assets.

  • March 25, 2026

    Insurers, Brokers Can't Exit Medicare Advantage Steering Suit

    A Massachusetts federal judge on Wednesday largely rejected a bid by insurers and brokers to toss claims that they colluded in a kickback scheme to steer Medicare Advantage customers to certain companies and to push away disabled individuals.

  • March 25, 2026

    Extreme Networks Must Face Suit Over COVID-Era Demand

    A California federal judge rejected Extreme Networks' bid to dismiss a suit alleging it misled investors about its financial prospects and declining client demand during the COVID-19 pandemic, saying the investors adequately pled that the cloud network equipment company engaged in a scheme to inflate revenues through so-called channel-stuffing.

  • March 25, 2026

    Conn. Regulators Approve $2.4B Eversource Water Co. Sale

    Connecticut's Public Utilities Regulatory Authority on Wednesday approved the transfer of Eversource subsidiary Aquarion Co. to a new public water authority created by the state Legislature, subject to several conditions, while admitting the $2.35 billion price tag placed the deal "on the knife's edge of a public interest finding."

  • March 25, 2026

    DOJ Defends FCA's Qui Tam Constitutionality At 5th Circ.

    The U.S. Department of Justice is urging the Fifth Circuit to reject a healthcare provider's attempt to upend an $8.2 million judgment by arguing the False Claims Act's whistleblower mechanism is unconstitutional, saying every other appeals court has rejected such a claim. 

  • March 25, 2026

    Mom Tying Abbott Formula To Baby's NEC Takes The Stand

    A plaintiff claiming Abbott Laboratories' preterm baby formula contributed to her infant's development of a serious gut condition told an Illinois jury Wednesday that she wouldn't have allowed her baby to consume the formula had she known it increased the risk of the infection, saying her now-teenage daughter still struggles with medical complications as a result.

  • March 25, 2026

    Estate Says OpenAI Suicide Suit Distinct From Murder Suit

    The estate of a man who murdered his mother and died by suicide allegedly because of his use of ChatGPT is urging a California federal court not to dismiss its suit against OpenAI, saying the suit doesn't run parallel to a state court case from the mother's estate.

  • March 25, 2026

    Lender Targets Borrower, Guarantor In $3.8M Default Suit

    A Delaware lender has sued a group of real estate investors and affiliated entities in Delaware Chancery Court, accusing them of defaulting on a $3.8 million mezzanine loan and then diverting collateral to avoid repayment.

  • March 25, 2026

    Turf Company Executive Can't Escape Trade Secrets Suit

    An executive must face a turf manufacturer's suit claiming he took confidential information with him when he jumped ship for a rival company, a Georgia federal judge ruled, but said a lack of plausible misconduct allegations meant that rival should be dismissed from the case. 

  • March 25, 2026

    Ashurst Adds 4 Ex-Bracewell Partners To Finance Practice

    Ashurst LLP has announced the addition of a four-partner team in New York to expand its finance and restructuring capacities ahead of a proposed merger with Perkins Coie LLP.

  • March 25, 2026

    Judge Trims SEC Fraud Case Over Cancer Drug Claims

    A Massachusetts federal judge greenlighted U.S. Securities and Exchange Commission claims against two of three former pharmaceutical executives accused of concealing from investors the U.S. Food and Drug Administration's "harsh critiques" about a cancer drug.

  • March 25, 2026

    Insurer Need Not Cover Parkinson's Drug Antitrust Dispute

    An insurer does not owe coverage in an antitrust suit accusing a pharmaceutical company of suppressing generic versions of the Parkinson's treatment Apokyn, a Maryland federal judge ruled, finding the dispute does not involve "securities claims" covered under the insurer's policy.

  • March 25, 2026

    Del. Chancellor Pauses Tesla Suit As Musk Cites LinkedIn Post

    The Delaware Chancery Court has paused a high-profile Tesla stockholder case following a recusal bid from Elon Musk and Tesla Inc. after a judge's LinkedIn account appeared to react to a post celebrating a recent California jury verdict against Musk, including language praising efforts to stand up to "the richest man in the world."

  • March 25, 2026

    Utah Expands Unrelated Biz Income Definition For Corp. Tax

    Utah will expand its definition of corporate income to include income allocated to the state under a bill signed by the state's governor.

  • March 25, 2026

    Jury Doubles Damages Against Meta, Google In LA Bellwether

    A California state jury that found Meta and Google liable Wednesday for harming the mental health of a woman who says she became addicted to their social media platforms as a child delivered a second blow later in the day, awarding $3 million in punitive damages on top of a $3 million compensatory award.

  • March 25, 2026

    High Court Reverses Music Piracy Liability Ruling Against Cox

    The U.S. Supreme Court on Wednesday said the Fourth Circuit incorrectly affirmed a jury verdict that found Cox Communications liable for its customers' music piracy, concluding there is a legal distinction between mere knowledge of infringement and intent to promote it.

  • March 24, 2026

    Pentagon 'Punishing' Anthropic Would Be Illegal, Judge Says

    A California federal judge considering Anthropic's request to block the U.S. Department of Defense from labeling it a supply chain national security risk said Tuesday that it looks like the government is "punishing" Anthropic for bringing public attention to their contract fight, a move that would violate the First Amendment.

  • March 24, 2026

    Meta Tackles Borrowed Underwear Analogy In Privacy Suit

    A California federal judge mulling Meta's argument that its users' consent bars a proposed privacy class action pressed Meta's lawyers Tuesday on whether social expectations affect the bounds of that consent, observing that if she gave a friend permission to borrow her clothes, "I don't expect her to borrow my underwear."

  • March 24, 2026

    Iowa Asks 5th Circ. To Ax 'Uncertain' Schwab Antitrust Deal

    Iowa's attorney general Monday pressed the Fifth Circuit to reject investors' deal with The Charles Schwab Corp. in an antitrust suit over its merger with TD Ameritrade, arguing it offers only uncertain and hypothetical relief to class members while giving named plaintiffs and class counsel a "windfall."

  • March 24, 2026

    AI Tools May 'Disrobe' Meta Of Section 230 Shield, Judge Says

    A California federal judge trimmed Tuesday a proposed class action alleging Meta Platforms Inc. knowingly participated in a Chinese pump-and-dump scheme advertised on social media, but found there's a factual dispute over whether Meta's AI tools materially contributed to the "facially ridiculous" ads.

  • March 24, 2026

    FINRA CEO Highlights New Clearinghouse For Cyber Threats

    Robert Cook, CEO of the Financial Industry Regulatory Authority, said Tuesday that it will soon be rolling out a clearinghouse for firms to report cybersecurity threats and to promote information sharing across the industry.

  • March 24, 2026

    Drug Co. Atara Hit With Investor Suit Over FDA Denial

    Drug company Atara Biotherapeutics Inc. has been hit with a proposed class action accusing it of harming investors by not disclosing certain manufacturing problems and research study deficiencies that made it unlikely the U.S. Food and Drug Administration would approve its new drug application.

  • March 24, 2026

    Delaware Court Tosses Allied Gaming Suit, Awards $5.9M Fees

    The Delaware Chancery Court on Tuesday dismissed a stockholder challenge to a disputed share issuance at Allied Gaming & Entertainment Inc. as moot, while ordering the company to pay nearly $5.94 million in attorney fees and expenses after finding that the litigation prompted the company to reverse course.

  • March 24, 2026

    Sarepta Urges Full Fed. Circ. To Wipe Out Gene Therapy IP

    Sarepta Therapeutics Inc. wants the full Federal Circuit to rethink a decision reviving a University of Pennsylvania gene therapy patent, saying a panel got its analysis of patent eligibility wrong.

Expert Analysis

  • How Internal Reporting Could Benefit Antitrust Whistleblowing

    Author Photo

    As the Justice Department's new antitrust whistleblower program stands to raise questions over the interaction between rewards and corporate leniency, incentivizing internal reporting first could increase the likelihood that the Antitrust Division receives the high-quality evidence needed to successfully prosecute cartel cases, says Daniel Oakes at Axinn.

  • What Texas Anti-Boycott Ruling Means For ESG Landscape

    Author Photo

    A Texas federal court's recent ruling in American Sustainable Business Council v. Hegar that Texas' anti-ESG law is unconstitutional on First Amendment grounds will likely embolden legal challenges to similar laws in other states that have adopted fossil fuel boycott statutes, say attorneys at ArentFox Schiff.

  • Series

    Law School's Missed Lessons: The Human Element

    Author Photo

    Law school teaches you to quickly apply intellect and logic when handling a legal issue, but every fact pattern also involves a person, making the ability to balance expertise with empathy critical to the growth of relationships with clients, colleagues and adversaries, says Rachel Adcox at Adcox Strategies.

  • 4 Ways To Help CBP Curb Shell Co. Import Schemes

    Author Photo

    Shifting to a proactive rather than reactive enforcement posture in addressing shell companies set up to skirt tariffs requires equipping U.S. Customs and Border Protection with enhanced investigative authorities, better intelligence support, and mechanisms to identify and hold accountable the ultimate illicit actors, say attorneys at Kelley Drye.

  • How DExit, Mandatory Arbitration Could Alter IPO Outlook

    Author Photo

    As companies continue to leave Delaware and the U.S. Securities and Exchange Commission begins allowing companies to implement mandatory arbitration provisions, these developments could have a major impact on the initial public offering, securities class action, and directors and officers insurance landscapes, says Walker Newell at Arthur J. Gallagher & Co.

  • Why Prediction Market Regulation Is At Major Inflection Point

    Author Photo

    As prediction markets experience tremendous growth and rapid mainstream adoption, regulators have begun to exercise enforcement authority to ensure market integrity and protect participants, though forthcoming guidance will shed light on how aggressively the agencies will police the fast-changing landscape, say attorneys at Latham.

  • The Benefits Of Choosing A Niche Practice In The AI Age

    Author Photo

    As artificial intelligence becomes increasingly accessible, lawyers with a niche practice may stand out as clients seek specialized judgment that automation cannot replicate, but it is important to choose a niche that is durable, engaging and a good personal fit, says Daniel Borneman at Lowenstein Sandler.

  • Risk Disclosure Lessons For AI Cos. From Dot-Com Era

    Author Photo

    Regulatory responses following the dot-com collapse reflected a consistent emphasis on whether public disclosures enabled investors to understand the economic reality underlying reported performance, a focus that is likely to shape how artificial intelligence infrastructure disclosures are evaluated if market expectations similarly deteriorate, say Diana Connor, Adrienna Huffman and Bin Zhou at the Brattle Group.

  • Section 122 Tariffs Show Shift In Strategy, Not Trade Policy

    Author Photo

    By imposing temporary tariffs under Section 122 of the Trade Act as a stopgap measure while it pivots to less transitory statutory authorities, the Trump administration sent a clear message that the U.S. Supreme Court’s decision in Learning Resources v. Trump, invalidating duties imposed under the International Emergency Economic Powers Act, will not precipitate a change in policy direction, say attorneys at Snell & Wilmer.

  • Series

    Podcasting Makes Me A Better Lawyer

    Author Photo

    Podcasting has changed how I ask questions and connect with people, sharpening my ability to listen without interrupting or prejudging, and bringing me closer to what law is meant to be: a human profession grounded in understanding, judgment and trust, says Donna DiMaggio Berger at Becker.

  • AG Watch: Ohio Targets DEI Policies

    Author Photo

    As Ohio Attorney General Dave Yost seeks to eliminate diversity, equity and inclusion programs in both public education institutions and private companies, Ohio entities must carefully navigate this constantly evolving, highly contentious topic to avoid litigation while also not forfeiting their core principles, say attorneys at BakerHostetler.

  • Del. Coinbase Outcome May Have Been Different In Texas

    Author Photo

    The Delaware Court of Chancery's recent decision in Grabski v. Andreessen, finding that a member of the Coinbase special litigation committee was not independent, provides guidance for Delaware boards regarding the formation, composition and operation of SLCs, while offering a counterpoint to the procedures available to Texas-incorporated companies, says John Lawrence at Baker Botts.

  • Why The NCUA's Stablecoin Moment Matters

    Author Photo

    The National Credit Union Administration, a historically conservative federal agency, recently proposed a detailed stablecoin licensing framework, confirming that the proposition of building a regulatory architecture within the banking industry has moved well past "whether" and firmly into "how," says Stephen Aschettino at Fox Rothschild.

  • Lessons From Justices' Split On Major Questions Doctrine

    Author Photo

    The justices' varied opinions in Learning Resources v. Trump, which held the International Emergency Economy Powers Act did not confer the power to impose tariffs, offer a meaningful window into the U.S. Supreme Court's perspective on the major questions doctrine that will likely shape lower courts' approach to executive action challenges, say attorneys at Venable.

  • Drug Wholesaler's DPA Shows Imperfect Efforts Still Count

    Author Photo

    Atlantic Biologicals’ recent deferred prosecution agreement with federal prosecutors for allegedly distributing controlled substances to pill mill pharmacies demonstrates that even subpar cooperation, when combined with genuine remediation and strategic advocacy, can yield outcomes that protect a company's long-term interests, says Jonathan Porter at Husch Blackwell.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Corporate archive.